Elevance Health vs United Health Products Which Is Superior?

Elevance Health and United Health Products are two companies in the health sector that offer investors unique opportunities for growth and profitability. Elevance Health specializes in innovative healthcare solutions and personalized wellness programs, making it a promising investment option for those interested in the rapidly evolving healthcare industry. On the other hand, United Health Products focuses on developing advanced wound care products and technologies, catering to a niche market with high demand. Both stocks present potential for long-term success and should be considered by astute investors looking to diversify their portfolios.

Elevance Health or United Health Products?

When comparing Elevance Health and United Health Products, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Elevance Health and United Health Products.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Elevance Health has a dividend yield of 1.72%, while United Health Products has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Elevance Health reports a 5-year dividend growth of 14.56% year and a payout ratio of 23.08%. On the other hand, United Health Products reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Elevance Health P/E ratio at 13.74 and United Health Products's P/E ratio at -8.84. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Elevance Health P/B ratio is 2.01 while United Health Products's P/B ratio is -6.95.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Elevance Health has seen a 5-year revenue growth of 1.03%, while United Health Products's is -1.00%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Elevance Health's ROE at 15.48% and United Health Products's ROE at 87.07%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $377.98 for Elevance Health and $0.06 for United Health Products. Over the past year, Elevance Health's prices ranged from $377.98 to $567.26, with a yearly change of 50.08%. United Health Products's prices fluctuated between $0.06 and $0.27, with a yearly change of 373.68%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.